cro.directory
← Compare landing

BioAgile Therapeutics vs Veeda Lifesciences

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/bioagiletherapeutics/veedalifesciences

CategoryBioAgile TherapeuticsVeeda Lifesciences
Listed sitecrocro
SummaryISO 9001:2015-certified CRO offering end-to-end clinical research services including Phase I–IV trials, medical writing, biostatistics, data management, and regulatory support across pharmaceuticals, nutraceuticals, devices, and biotech.Veeda Lifesciences is a contract research organization offering preclinical R&D, BA/BE and bioanalytical studies, and Phase I–IV clinical trials for innovative, biosimilar, and generic drugs. Its capabilities cover both small and large molecules, including clinical bioanalysis and real-world evidence.
Services
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Operations
  • Data Management & eClinical
  • Biostatistics & Statistical Programming
  • Medical Writing
  • Regulatory Affairs
  • Pharmacovigilance & Drug Safety
  • Discovery Research
  • Preclinical In Vivo Studies
  • Bioanalysis
  • Analytical Method Development & Validation
  • Phase I Clinical Trials
  • Phase II Clinical Trials
  • Phase III Clinical Trials
  • Phase IV / Post-Marketing
  • Clinical Trial Services
  • Clinical Operations
  • Medical Writing
  • Pharmacovigilance & Drug Safety
  • Regulatory Affairs
  • Data Management & eClinical
ModalitiesData not yet provided.
  • Small Molecule
  • Biologics (Other)
IndicationsData not yet provided.Data not yet provided.
Locations
  • Headquarters, Bangalore, Karnataka, India
Data not yet provided.
Certifications
  • CDSCO · Identifier: CRO/KA/2026/000173
  • ISO · Identifier: ISO 9001:2015
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.